CD4+ T cell–innate immune crosstalk is critical during Staphylococcus aureus craniotomy infection
Access to the brain for treating neurological sequalae requires a craniotomy, which can be complicated by infection. Staphylococcus aureus accounts for half of craniotomy infections, increasing morbidity in a medically fragile patient population. T cells preferentially traffic to the brain during craniotomy infection; however, their functional importance is unknown. Using a mouse model of S. aureus craniotomy infection, CD4+ T cells were critical for bacterial containment, as treatment of WT animals with anti-CD4 exacerbated infection that was similar to phenotypes in Rag1-/- mice. Single-cell RNA-Seq (scRNA-Seq) revealed transcriptional heterogeneity in brain CD3+ infiltrates, with CD4+ cells most prominent that displayed Th1- and Th17-like characteristics, and adoptive transfer of either subset in Rag1-/- animals during early infection prevented S. aureus outgrowth. scRNA-Seq identified a robust IFN signature in several innate immune clusters, and examination of cell-to-cell interactions revealed extensive T cell crosstalk with monocytes/macrophages that was also observed in human craniotomy infection. A cooperative role for Th1 and Th17 responses was demonstrated by treatment of Ifng-/- mice with IL-17A neutralizing antibody that recapitulated phenotypes in Rag1-/- animals. Collectively, these findings implicate Th1- and Th17-mediated proinflammatory responses in shaping the innate immune landscape for S. aureus containment during craniotomy infection.
Authors
- Rachel W. Fallet
- Tammy Kielian (ORCID: https://orcid.org/0000-0001-7624-670X)
- Lee E. Korshoj (ORCID: https://orcid.org/0000-0003-3514-1404)
- Zachary Van Roy (ORCID: https://orcid.org/0000-0002-6015-8411)
- Gunjan Kak
Publication Details
- Journal
- JCI Insight
- Published
- 2025-02-23
- DOI
- https://doi.org/10.1172/jci.insight.183327
- Citations
- 1
- Primary Topic
- Immune Response and Inflammation
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke